NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
Comprehensive Review for the NCLEX-RN® Examination, 5thEdition
n n n n n n n
Pharmacologyn
TestnBank
MULTIPLEnCHOICE
1. Then nursen isn caringn forn an client n inn labor.n Then nursen reviewsn then physician’sn prescriptionsn and n notesn that nthe
n client n hasn an prescriptionn forn butorphanoln tartraten (Stadol).n Then nursen understandsnthatn thisn medicationnisn pr
escribed n for:
1. Painn relief
2. Increasingn uterinen contractions
3. Decreasingn uterinen contractions
4. Promotingn fetaln lungn maturity
ANS:n 1
Rationale:nThen client n inn laborn mayn ben givenn parenteraln analgesian duringn then first n stagen ofnlabor,n upn ton2n ton3n
hoursn beforen then anticipated n delivery.n Butorphanoln tartratenisn an medicationn thatn mayn benprescribed n forn painn
relief.n “Increasingn uterinen contractions,”n “decreasingn uterinen contractions,”n and n “promotingn fetaln lungn mat
urity”n aren not n actionsn of n thisn medication.
Test-
TakingnStrategy:nKnowledgen of n then actionn of n butorphanoln tartraten isn required n ton answern thisn question.n Re
membern that n thisn medicationn isn used nforn painn relief.n Review n thenactionn ofnthisn medicationn if nyounhadn difficul
tyn withn thisn questionn and n aren unfamiliarn withn thisn medication.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF:
Lehne,n R.n (2010).n Pharmacologyn forn nursingn caren (7thn ed.).n St.n Louis:n Saunders.n
OBJ: Client n Needs:n Physiologicaln Integrity
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Planning
2. Then postpartumn nursen isn caringn forn an client n withn ann epiduraln cathetern inn placen forn opioid n analgesicna
dministrationn followingn cesareann birth.n If n then client n developsn respiratoryn depressionn and n requiresnn
aloxonen (Narcan)n asn ann antidote,n then client n mayn complainn of n whichn of n then following?
1. Increasen inn hern painn level
2. Decreasen inn hern painn level
,NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
3. Increasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural
4. Decreasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural
,NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
ANS:n 1
Rationale:nRemembern that n opioidsn aren used n forn epiduraln analgesia.n Naloxonen isn ann opioid nantagonist,nwhic
hn reversesn then effectsn ofn opioids.nIf nit nisn given,n thenclient n mayn complainn of n annincreasen inn hern painn level.n The
reforen “decreasen inn hern painn level,”n “increasen inn then amount n of n itchingnfromn then opioid nusedn inn thenepidural,
”n and n “decreasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural”n aren incorrect.
Test-
TakingnStrategy:nTonanswernthisn questionn accurately,n youn must n know nthat nopioid n analgesicsnarenthenmedicati
onsn used n withn epiduraln analgesian ton relieven pain.n Thereforen if n naloxonen isn administered n asn annantidoten forn ann
opioid n analgesic,n then client’sn painn willn increase.n Review n then effectsnof nnaloxonen if nthisn questionnwasn difficult
.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF:
Lehne,n R.n (2010).n Pharmacologyn forn nursingn caren (7thn ed.).n St.n Louis:n Saunders.n
OBJ: Client n Needs:n Physiologicaln Integrity
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Assessment
3. An client n experiencingn pretermn laborn at n then twenty-
ninthn weekn of n gestationn hasn beennadmittedn ton thenhospital.n Then client n hasnan prescriptionn tonreceiven betamet
hasonen (Celestone).n Then nursen understandsn that nt hen medicationn willn don whichn of n then following?
1. Prevent nspontaneousn delivery.
2. Stopn then uterinen contractions.
3. Promoten maturationn of n then fetaln lungs.
4. Acceleraten then growthn raten of n then fetus.
ANS:n 3
Rationale:nBetamethasonen (Celestone)n isn classified n asn ann anti-
inflammatoryn and n corticosteroid.n It nincreasesn then surfactantn leveln andn lungnmaturityn inn then fetus,n whichn red
ucesn then incidencen of n respiratoryn distressn syndrome.n Deliveryn must n bendelayed nforn atn least n48nhoursn aftern ad
ministrationn of n betamethasonent on allow n timen forn then lungsn of n then fetusn ton mature.
Test-
TakingnStrategy:nOptionsn that n aren comparablen orn aliken aren not n likelyn ton ben correct.n Withnthisn inn mind,nelimi
naten “prevent n spontaneousn delivery”n and n“stopnthenuterinen contractions.”n Notenthenstrategicn wordsn“twenty
-
ninthn weekn of n gestation.”n Specificn knowledgenaboutn thenmedicationn andnknowledgen ofnthenproblemsn encoun
tered n byn prematuren infantsn willn assist n inn answeringn thisn question.n Review nthenactionn ofnthisn medicationn if nth
isn questionn wasn difficult.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF: McKinney,n E.,n James,n S.,n Murray,n S.,n &nAshwill,n J.n (2009).n Maternal-
child n nursingn (3rd n ed.).n St.nLouis:n Saunders. OBJ: Client n Needs:n Physiologicaln Integrity
, NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Planning
4. An client n withn preeclampsian isn receivingn magnesiumn sulfate.n Then nursen assessesn then client n closelyn forn
whichn signn of n magnesiumn toxicity?
1. Proteinuria
2. Hyperactiven deepn tendonn reflexes
3. Respiratoryn raten of n 10n breaths/min
4. Serumn magnesiumn leveln of n 5n mEq/L
ANS:n 3
Rationale:nMagnesiumn toxicityn isn an riskn associated n withn magnesiumn sulfaten therapy.n Signsn of n magnesiumnt
oxicityn relaten ton centraln nervousn systemn (CNS)n depressionn and n includenrespiratoryn depression,n lossn of ndeepn
tendonn reflexes,n and n suddenn dropn inn fetaln heart n raten and/orn maternaln heart n raten and n blood n pressure.
Magnesiumn isn excreted n throughn then kidneys.n Ifn renaln impairment n isn present,n magnesiumn toxicityn canndevelop
n veryn quickly.n Therapeuticn serumn levelsn of n magnesiumn aren 4n ton 7n mEq/L.
Test-
TakingnStrategy:nTon answern thisn questionn accurately,n youn must n recalln that n magnesiumn sulfaten isn an CNSn de
pressant.n Beginn ton answern thisn questionn byneliminatingn “proteinuria”n and n “hyperactiven deepntendonnreflexe
s,”n whichn aren signsn of n preeclampsia.n Select n betweenn thenlast n twonoptionsn usingn medicationnknowledgenandn r
ecallingn that n then therapeuticn serumn levelsn of n magnesiumn aren 4n ton 7nmEq/L.n Review n thisn medicationn andnthen
normaln magnesiumn leveln if n thisn questionn wasn difficult.
PTS: 1
DIF: Leveln of n CognitivenAbility:nAnalyzing
REF: Lowdermilk,n D.,n Perry,n S.,n &n Cashion,n K.n (2010).n Maternityn nursingn (8thn ed.).n St.n Louis:n Mosby.
OBJ:
Client n Needs:n Physiologicaln IntegritynTOP:
Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Assessment
5. An pregnant n client n whon hasn humannimmunodeficiencyn virusn (HIV)ninfectionn isn beingn seenninn thenantenatalncl
inic.n Then nursen recallsn that n zidovudinen (AZT)n therapyn willn ben initiated nwhennthenfetusn hasnreached n hownma
nyn weeksn of n gestation?
1. 4
2. 14
3. 24
4. 34
ANS:n 2
Rationale:nThen pregnant n womenn withn HIVninfectionnwilln ben prescribed n oralnAZTninn thenfourteenthnweeknofn
gestation.n Beforen thisn time,n then fetusn isn at n riskn becausen of n then teratogenicn effectsn of n then medication.n In
n n n n n n
Comprehensive Review for the NCLEX-RN® Examination, 5thEdition
n n n n n n n
Pharmacologyn
TestnBank
MULTIPLEnCHOICE
1. Then nursen isn caringn forn an client n inn labor.n Then nursen reviewsn then physician’sn prescriptionsn and n notesn that nthe
n client n hasn an prescriptionn forn butorphanoln tartraten (Stadol).n Then nursen understandsnthatn thisn medicationnisn pr
escribed n for:
1. Painn relief
2. Increasingn uterinen contractions
3. Decreasingn uterinen contractions
4. Promotingn fetaln lungn maturity
ANS:n 1
Rationale:nThen client n inn laborn mayn ben givenn parenteraln analgesian duringn then first n stagen ofnlabor,n upn ton2n ton3n
hoursn beforen then anticipated n delivery.n Butorphanoln tartratenisn an medicationn thatn mayn benprescribed n forn painn
relief.n “Increasingn uterinen contractions,”n “decreasingn uterinen contractions,”n and n “promotingn fetaln lungn mat
urity”n aren not n actionsn of n thisn medication.
Test-
TakingnStrategy:nKnowledgen of n then actionn of n butorphanoln tartraten isn required n ton answern thisn question.n Re
membern that n thisn medicationn isn used nforn painn relief.n Review n thenactionn ofnthisn medicationn if nyounhadn difficul
tyn withn thisn questionn and n aren unfamiliarn withn thisn medication.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF:
Lehne,n R.n (2010).n Pharmacologyn forn nursingn caren (7thn ed.).n St.n Louis:n Saunders.n
OBJ: Client n Needs:n Physiologicaln Integrity
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Planning
2. Then postpartumn nursen isn caringn forn an client n withn ann epiduraln cathetern inn placen forn opioid n analgesicna
dministrationn followingn cesareann birth.n If n then client n developsn respiratoryn depressionn and n requiresnn
aloxonen (Narcan)n asn ann antidote,n then client n mayn complainn of n whichn of n then following?
1. Increasen inn hern painn level
2. Decreasen inn hern painn level
,NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
3. Increasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural
4. Decreasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural
,NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
ANS:n 1
Rationale:nRemembern that n opioidsn aren used n forn epiduraln analgesia.n Naloxonen isn ann opioid nantagonist,nwhic
hn reversesn then effectsn ofn opioids.nIf nit nisn given,n thenclient n mayn complainn of n annincreasen inn hern painn level.n The
reforen “decreasen inn hern painn level,”n “increasen inn then amount n of n itchingnfromn then opioid nusedn inn thenepidural,
”n and n “decreasen inn then amount n of n itchingn fromn then opioid n used n inn then epidural”n aren incorrect.
Test-
TakingnStrategy:nTonanswernthisn questionn accurately,n youn must n know nthat nopioid n analgesicsnarenthenmedicati
onsn used n withn epiduraln analgesian ton relieven pain.n Thereforen if n naloxonen isn administered n asn annantidoten forn ann
opioid n analgesic,n then client’sn painn willn increase.n Review n then effectsnof nnaloxonen if nthisn questionnwasn difficult
.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF:
Lehne,n R.n (2010).n Pharmacologyn forn nursingn caren (7thn ed.).n St.n Louis:n Saunders.n
OBJ: Client n Needs:n Physiologicaln Integrity
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Assessment
3. An client n experiencingn pretermn laborn at n then twenty-
ninthn weekn of n gestationn hasn beennadmittedn ton thenhospital.n Then client n hasnan prescriptionn tonreceiven betamet
hasonen (Celestone).n Then nursen understandsn that nt hen medicationn willn don whichn of n then following?
1. Prevent nspontaneousn delivery.
2. Stopn then uterinen contractions.
3. Promoten maturationn of n then fetaln lungs.
4. Acceleraten then growthn raten of n then fetus.
ANS:n 3
Rationale:nBetamethasonen (Celestone)n isn classified n asn ann anti-
inflammatoryn and n corticosteroid.n It nincreasesn then surfactantn leveln andn lungnmaturityn inn then fetus,n whichn red
ucesn then incidencen of n respiratoryn distressn syndrome.n Deliveryn must n bendelayed nforn atn least n48nhoursn aftern ad
ministrationn of n betamethasonent on allow n timen forn then lungsn of n then fetusn ton mature.
Test-
TakingnStrategy:nOptionsn that n aren comparablen orn aliken aren not n likelyn ton ben correct.n Withnthisn inn mind,nelimi
naten “prevent n spontaneousn delivery”n and n“stopnthenuterinen contractions.”n Notenthenstrategicn wordsn“twenty
-
ninthn weekn of n gestation.”n Specificn knowledgenaboutn thenmedicationn andnknowledgen ofnthenproblemsn encoun
tered n byn prematuren infantsn willn assist n inn answeringn thisn question.n Review nthenactionn ofnthisn medicationn if nth
isn questionn wasn difficult.
PTS: 1
DIF: Leveln of n CognitivenAbility:n Understanding
REF: McKinney,n E.,n James,n S.,n Murray,n S.,n &nAshwill,n J.n (2009).n Maternal-
child n nursingn (3rd n ed.).n St.nLouis:n Saunders. OBJ: Client n Needs:n Physiologicaln Integrity
, NCLEX-RN® Examination, 5th Edition Pharmacology Test Bank
n n n n n n
TOP: Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Planning
4. An client n withn preeclampsian isn receivingn magnesiumn sulfate.n Then nursen assessesn then client n closelyn forn
whichn signn of n magnesiumn toxicity?
1. Proteinuria
2. Hyperactiven deepn tendonn reflexes
3. Respiratoryn raten of n 10n breaths/min
4. Serumn magnesiumn leveln of n 5n mEq/L
ANS:n 3
Rationale:nMagnesiumn toxicityn isn an riskn associated n withn magnesiumn sulfaten therapy.n Signsn of n magnesiumnt
oxicityn relaten ton centraln nervousn systemn (CNS)n depressionn and n includenrespiratoryn depression,n lossn of ndeepn
tendonn reflexes,n and n suddenn dropn inn fetaln heart n raten and/orn maternaln heart n raten and n blood n pressure.
Magnesiumn isn excreted n throughn then kidneys.n Ifn renaln impairment n isn present,n magnesiumn toxicityn canndevelop
n veryn quickly.n Therapeuticn serumn levelsn of n magnesiumn aren 4n ton 7n mEq/L.
Test-
TakingnStrategy:nTon answern thisn questionn accurately,n youn must n recalln that n magnesiumn sulfaten isn an CNSn de
pressant.n Beginn ton answern thisn questionn byneliminatingn “proteinuria”n and n “hyperactiven deepntendonnreflexe
s,”n whichn aren signsn of n preeclampsia.n Select n betweenn thenlast n twonoptionsn usingn medicationnknowledgenandn r
ecallingn that n then therapeuticn serumn levelsn of n magnesiumn aren 4n ton 7nmEq/L.n Review n thisn medicationn andnthen
normaln magnesiumn leveln if n thisn questionn wasn difficult.
PTS: 1
DIF: Leveln of n CognitivenAbility:nAnalyzing
REF: Lowdermilk,n D.,n Perry,n S.,n &n Cashion,n K.n (2010).n Maternityn nursingn (8thn ed.).n St.n Louis:n Mosby.
OBJ:
Client n Needs:n Physiologicaln IntegritynTOP:
Content nArea:n Pharmacology
MSC:n Integrated n Process:n Nursingn Process—Assessment
5. An pregnant n client n whon hasn humannimmunodeficiencyn virusn (HIV)ninfectionn isn beingn seenninn thenantenatalncl
inic.n Then nursen recallsn that n zidovudinen (AZT)n therapyn willn ben initiated nwhennthenfetusn hasnreached n hownma
nyn weeksn of n gestation?
1. 4
2. 14
3. 24
4. 34
ANS:n 2
Rationale:nThen pregnant n womenn withn HIVninfectionnwilln ben prescribed n oralnAZTninn thenfourteenthnweeknofn
gestation.n Beforen thisn time,n then fetusn isn at n riskn becausen of n then teratogenicn effectsn of n then medication.n In
